Related Experiment Video
Updated: Apr 29, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.2K
Predicting recurrent venous thromboembolism in cancer: is it possible?
1Department of Medicine I, Medical University of Vienna; Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria.
Thrombosis Research
|May 28, 2014
Summary
Identifying cancer patients at high risk for recurrent venous thromboembolism (VTE) is crucial. The Ottawa score, using clinical factors, helps stratify this risk, guiding treatment decisions for better outcomes.
Area of Science:
- Oncology
- Hematology
- Clinical Risk Stratification
Background:
- The link between cancer and venous thromboembolism (VTE) is established, but recurrent VTE in cancer patients is less understood.
- Current anticoagulation for cancer-associated VTE (CAVTE) has a 10% recurrence risk and higher bleeding rates compared to non-cancer patients.
- Improved strategies are needed to personalize anticoagulation duration and intensity based on individual recurrence risk.
Purpose of the Study:
- To evaluate the utility of a novel risk assessment model (RAM) for predicting recurrent VTE in cancer patients.
- To assess the role of clinical risk factors in determining VTE recurrence in this population.
Main Methods:
- A risk assessment model (RAM), the Ottawa score, was developed using 4 clinical patient characteristics: sex, cancer type and stage, and history of VTE.
- The RAM's predictive performance for recurrent VTE was validated in over 800 patients from two prospective studies.
Main Results:
- The Ottawa score successfully stratified cancer patients based on their risk of VTE recurrence.
- The model combines key clinical factors to predict the likelihood of experiencing a repeat VTE event.
Conclusions:
- The Ottawa score offers a validated tool for identifying cancer patients at high risk for recurrent VTE.
- Further management studies and impact analyses are necessary before widespread clinical implementation of this risk assessment model.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Venous Thrombosis I: Introduction
812
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
812
01:30Venous Thrombosis IV: Nursing Management
415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
467
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
467
01:27Pulmonary Embolism III: Nursing Management
751
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
751
01:19Pulmonary Embolism I: Introduction
37
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
37